Fingerprint
Dive into the research topics of 'Dipeptidyl-peptidase IV inhibitor (DPP4i) confers increased odds of bullous pemphigoid even years after drug initiation'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Dipeptidyl-peptidase IV inhibitor (DPP4i) confers increased odds of bullous pemphigoid even years after drug initiation
Khalaf Kridin, Orly Avni, Giovanni Damiani, Dana Tzur Bitan, Erez Onn, Orly Weinstein, Arnon D. Cohen
- Faculty of Health Sciences
- Department of Psychology
- Ben-Gurion University of the Negev
- Bar-Ilan University - Azrieli Faculty of Medicine
- Bar-Ilan University
- Ariel University
Ben-Gurion University of the Negev, Ariel University, Bar-Ilan University
Research output: Contribution to journal › Article › peer-review